You've heard of Ozempic, but do you understand how it works?
Ozempic is a master mimicker of the hormone GLP-1, which helps the pancreas release insulin. It also acts on the brain to reduce hunger.
Stay updated with breaking news from Fatty Liver Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ozempic is a master mimicker of the hormone GLP-1, which helps the pancreas release insulin. It also acts on the brain to reduce hunger.
Naim Alkhouri, MD, FAASLD, to Present Findings from Non-alcohol Related Fatty Liver Disease Feasibility Study Better Therapeutics, Inc. (NASDAQ:BTTX), a prescription digital therapeutics (PDT) company developing a
SAN FRANCISCO, June 16, 2023--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based, novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, today announced the details of its poster presentation at the European Association for the Study of the Liver (EASL) Congress 2023, being held from June 21-24 in Vienna, Austria. EASL is a leading professional society and
There is some concern that the prevalence of diseases like NASH and NAFLD may increase in the coming years.
Product development should factor in the unique, complex needs of patients with NAFLD, the authors say.